|
Journal of Cancer Research and Therapeutics, Vol. 7, No. 3, July-September, 2011, pp. 387-389 Letter to the Editor - Documenting a Case Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography Subhash K Ramani1, Sandip Basu2, Vani Parmar3, Sumeet Gujral4, Sandip Bibte3 1 Department of Radiology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India Correspondence Address: Sandip Basu, Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel, Mumbai - 400 012, Maharashtra, India, drsanb@yahoo.com A second primary in the breast in a patient of gastrointestinal stromal tumor (GIST) is described in this report. This was a serendipitous observation on the whole body flouro-deoxy glucose-positron emission tomography (FDG-PET) study. The patient, a 49-year-old female, an operated case of gastric GIST, underwent FDG-PET for a whole body disease survey and did not show any abnormal disease focus except for an intense (SUVmax 4.3) focus in the left breast [Figure - 1]. The patient underwent mammography and guided biopsy to correlate this incidentally detected FDG-avid focus in the breast [Figure - 2]. The final histopathology turned out to be infiltrating ductal carcinoma grade III [Figure - 3], with triple negative breast carcinoma on immunohistochemistry. Several second primaries in the setting of GIST have been reported in the literature. The present association, to the best of our knowledge, is the first report of breast carcinoma in the setting of GIST. Synchronous or metachronous second primaries in the setting of GIST have been reported in the literature including that of the non-GI system. [1],[2],[3],[4],[5] There is a solitary report of the association of carcinoma breast and GIST. [2] With the improved patient survival in GIST, reports of its association with other neoplasms are becoming more common. The present case upholds the value of incidental observation in whole body FDG-PET and the fact that disease may be detected when it is confined to the site of primary. Concurrent two different primary malignancies detected by whole body FDG-PET or PET/CT have been described to be of distinct advantage and the present observation of diagnosing this unsuspected second primary malignancy further substantiates this. References
Copyright 2011 - Journal of Cancer Research and Therapeutics The following images related to this document are available:Photo images[cr11102f3.jpg] [cr11102f2.jpg] [cr11102f1.jpg] |
|